All the latest from Invest Liverpool
iiCON SECURES OVER £150 MILLION INVESTMENT AND CREATES 176 JOBS IN FIRST YEAR SINCE LAUNCH
Infection Innovation Consortium (iicon)
-
iiCON SECURES OVER £150 MILLION INVESTMENT AND CREATES 176 JOBS IN FIRST YEAR SINCE LAUNCH
Since launching in September 2020, the Infection Innovation Consortium (iiCON) has established itself as a leading global centre for infectious disease R&D and created 176 high value jobs in the North West.
-
Liverpool agency Studio Coact appointed to deliver new infectious disease innovation and research website
The Infection Innovation Consortium (iiCON), a leading global centre of infectious disease innovation and R&D, has appointed the branding, web design, and digital marketing agency, Studio Coact, to deliver its new website following a competitive tender process.
-
IICON VALIDATED COVID TEST WILL SEE PRODUCT USED ACROSS AFRICA
A rapid COVID-19 antigen test, validated by researchers at Liverpool School of Tropical Medicine (LSTM) through the Infection Innovation Consortium (iiCON), will be used to deliver large-scale testing in key areas of need in Africa as part of a major FIND and UNITAID programme.
-
Liverpool-led partnership advances COVID-19 treatments
A new experimental model that accurately replicates the impact of respiratory infections on the lungs and upper airways has been developed by a Liverpool-led partnership between academics and business.